VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS20052473 | HPV | ENSG00000183044.12 | protein_coding | ABAT | No | No | 18 | P80404 X5D8S1 |
TVIS20046137 | HPV | ENSG00000183044.12 | protein_coding | ABAT | No | No | 18 | P80404 X5D8S1 |
TVIS44023827 | HTLV-1 | ENSG00000183044.12 | protein_coding | ABAT | No | No | 18 | P80404 X5D8S1 |
TVIS44047437 | HTLV-1 | ENSG00000183044.12 | protein_coding | ABAT | No | No | 18 | P80404 X5D8S1 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | ABAT |
---|---|
DrugBank ID | DB01080 |
Drug Name | Vigabatrin |
Target ID | BE0000253 |
UniProt ID | P80404 |
Regulation Type | inhibitor |
PubMed IDs | 10195585; 10206175 |
Citations | Weber OM, Verhagen A, Duc CO, Meier D, Leenders KL, Boesiger P: Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography. Magn Reson Imaging. 1999 Apr;17(3):417-25.@@Valdizan EM, Garcia AP, Armijo JA: Effects of increasing doses of vigabatrin on platelet gamma-aminobutyric acid-transaminase and brain gamma-aminobutyric acid in rats. Eur J Pharmacol. 1999 Mar 19;369(2):169-73. |
Groups | Approved |
Direct Classification | Gamma amino acids and derivatives |
SMILES | NC(CCC(O)=O)C=C |
Pathways | |
PharmGKB | PA10231 |
ChEMBL | CHEMBL89598 |